CLINICAL_TRIALS
trial_result
· 2024-03-01
Clinical Trial Update: A Phase 2 Study of Hemay007 in Patients With Rheumatoid Arthritis [Phase 2]
Summary
Phase 2 clinical trial update for Hemay007 in patients with rheumatoid arthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED